BXNDA — BLS Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$211.42m
- AU$209.18m
- AU$29.29m
Brief: Bioxyne Executes Sale And Purchase Agreement To Acquire Breathe Life Sciences
Australia's Bioxyne hits 2-week low on drop in HY23 sales revenue
Brief: Bioxyne Says Enters Into Binding Term Sheet To Acquire Breathe Life Sciences
Australia's Bioxyne rises on acquisition of health and wellness firm
Brief: Bioxyne Records Qtrly Sales Revenue A$0.5 Million
Bioxyne hits highest since Jan on deal with Singapore PE group
Brief: Bioxyne Joins Asian Partner & Sells 49% Of Direct Selling Business
Brief: Bioxyne Says March Revenues 147% Up Quarter On Quarter
Australia Stock Exchange release from BIOXYNE : Change of Director's Interest Notice
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 11:53:36
Australia Stock Exchange release from BIOXYNE : Appendix 4D and Interim Report
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:03:00
Australia Stock Exchange release from BIOXYNE : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from BIOXYNE : Results of Meeting
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:11:07
Australia Stock Exchange release from BIOXYNE : Reinstatement to Official Quotation
Australia Stock Exchange release from BIOXYNE : Bioxyne Not to Proceed with Proposed Acquisition
Australia Stock Exchange release from BIOXYNE : Letter to Shareholders on Annual General Meeting
Australia Stock Exchange release from BIOXYNE : Notice of Annual General Meeting/Proxy Form